CV Lattes
ResearcherID
ORCID
Universidade de São Paulo (USP). Instituto de Química (IQ) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduated in Chemistry (Bachelor's and Education Degree, University of São Paulo), Doctor of Science (Ph.D, University of São Paulo), and Researcher in pharmaceutical sciences with an international internship at Leslie Dan Faculty of Pharmacy, University of Toronto. I have 8+ years of experience in bioinorganic related to the development of new drugs and in nanotechnology of nanoparticles for drug delivery to cancer treatment. Currently, I have developed formulations using nanotechnology and researched 3D tumor models at the Nanotechnology and Tissue Engineering Center (FFCL-RP USP). I have teaching sciences and chemistry in basic education from 9th to 3rd grade of EM, and I have worked in science education with the series "Nanotecnologia Descomplicada" and "Nanomedicina no tratamento de câncer" in collaboration with the Synapse Pharma's YouTube channel. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Ruthenium compounds have received great attention in the field of metallodrugs because of their potential as anticancer agents. Complexes containing Ru2(II,III) dimetal cores coordinated to Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) developed in our research group have shown promising results in studies in vitro and in vivo in glioma models, such as the glioblastoma multiforme, a high…
Complexes of Cu(II) with non-steroidal anti-inflammatory drugs (NSAIDs) have relevance in the field of the development of new metal-based drugs. These complexes show interest due to both the anti-inflammatory activity and the reduced side-effects compared to the correspondent parent organic drugs of clinical use. The main objective of the present project is the investigation of the intera…
Ruthenium compounds have received great attention in the field of metallodrugs because of their potential as anticancer agents. Complexes containing Ru2(II,III) dimetal cores coordinated to non-steroidal anti-inflammatory drugs (NSAIDs) developed in our research group have shown promising results in studies in vitro and in vivo in glioma models, such as the glioblastoma multiforme, a high…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |